Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Newlink Genetics Corporation

Clinical trials sponsored by Newlink Genetics Corporation, explained in plain language.

Immune booster shows promise in tough pancreatic cancer trial

Disease control Completed

This study tested an experimental drug called indoximod, which aims to boost the immune system, together with standard chemotherapy for people with metastatic pancreatic cancer (cancer that has spread). The trial involved 157 adults and had two parts: first to find the safest dos…

Phase: PHASE1, PHASE2 • Sponsor: NewLink Genetics Corporation • Aim: Disease control

Last updated May 26, 2026 04:38 UTC